Check out your Company Bowl for anonymous work chats.
EECO2's ICCS® technology brings dynamic cleanroom control to pharmaceutical facilities — adjusting airflow in real time based on live contamination and particle data, rather than running at fixed rates regardless of need. Deployed across more than 300 life science sites globally, it has delivered up to 80% reductions in cleanroom energy consumption. Compliant with EU GMP Annex 1, it's innovation grounded in evidence, not theory.
EECO2 has recently secured B Corp Certification, SBTi-approved emissions targets, and an EcoVadis sustainability medal — three independently verified recognitions achieved within the same period. The business continues to grow, serving clients including GSK, AstraZeneca, Pfizer, and Moderna, with new roles open at Macclesfield HQ across engineering and operations. Momentum is backed by evidence, not just ambition.
EECO2 holds itself to the same standards it sets for clients. As a certified B Corporation with SBTi-approved climate targets, we've committed to reducing Scope 1 and 2 emissions by 42% by 2030, reaching net zero by 2035. EcoVadis independently places us in the top 35% of assessed companies in our category. These are verified, published commitments — not aspirations. Our community is built around accountability as much as ambition.
🌱 Culture At EECO2, work carries genuine weight. The team helps leading pharmaceutical organisations reduce carbon emissions and energy use in tightly regulated environments. That context shapes everything — standards are high, the pace is real, and outcomes matter. Our EECOTrac methodology turns complex challenges into clear, measurable action. If you want technical work that directly contributes to meaningful environmental change, this is a place built for that purpose
